To explore the underlying molecular mechanisms, we further confirmed the expression of genes related to the cell cycle, MAPK signaling and PI3K-AKT signaling activation in the shBTG2 or GV-BTG2 ovarian cancer cells (Figures 5A, B). This evidence concerns the gene AKT1 and ovarian carcinoma.